Hogan Lovells Cadwalader has advised Outlook Therapeutics, Inc. Outlook Therapeutics, Inc. has obtained U.S. Food and Drug Administration (FDA) approval for LYTENAVA™ (bevacizumab-vikg), marking the company’s...
FDA Approves Outlook Therapeutics’ Lytenava for Wet Age-Related Macular Degeneration
FDA Approves ZYCUBO® as First Treatment for Menkes Disease in the U.S.
Hogan Lovells has advised Sentynl Therapeutics Inc. Sentynl Therapeutics Inc., a U.S.-based biopharmaceutical company wholly owned by Zydus Lifesciences Limited, has received approval from the U.S....
Danco Laboratories’ Obtain Administrative Stay on Mifeprex Drug
Hogan Lovells has advised Danco Laboratories in the trial. Danco Laboratories has obtained an administrative stay in a case over Danco’s drug Mifeprex® (mifepristone) Tablets. On...